Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Revenue

Silva Pharmaceuticals had revenue of 107.64M BDT in the quarter ending March 31, 2025, a decrease of -38.24%. This brings the company's revenue in the last twelve months to 431.68M, down -29.42% year-over-year. In the fiscal year ending June 30, 2024, Silva Pharmaceuticals had annual revenue of 599.66M, down -16.35%.

• Revenue (ttm): 431.68M
• Revenue Growth: -29.42%
• P/S Ratio: 3.95
• Revenue / Employee: 627.45K
• Employees: 596
• Market Cap: 1.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	599.66M	-117.21M	-16.35%
Jun 30, 2023	716.87M	-61.80M	-7.94%
Jun 30, 2022	778.67M	-20.58M	-2.57%
Jun 30, 2021	799.25M	35.91M	4.70%
Jun 30, 2020	763.34M	30.89M	4.22%